CIK: 0001615982
Total reported value
$2.7B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CNST | Constellation Pharmaceutical | Stock-Other | 17.01% | — | — | |
| 2 | OLMA | Olema Pharmaceuticals INC | Stock-Other | 10.86% | — | — | |
| 3 | TREUR | Trillium Therapeutics INC | Stock-Other | 8.74% | — | -43.92% | |
| 4 | KNTEUSD | Kinnate Biopharma INC | Stock-Other | 8.62% | — | — | |
| 5 | ✓ | Athira Pharma INC | Stock-Other | 8.52% | — | +11.17% | |
| 6 | ALT | Altimmune INC | Stock-Other | 7.46% | — | — | |
| 7 | KROS | Keros Therapeutics INC | Stock-Other | 6.97% | — | — | |
| 8 | MRNS* | Marinus Pharmaceuticals INC | Stock-Other | 4.64% | — | — | |
| 9 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 3.65% | — | +78.24% | |
| 10 | RLMD | Relmada Therapeutics INC | Stock-Other | 3.15% | +1.26% | NEW | |
| 11 | KURA | Kura Oncology INC | Stock-Other | 2.76% | — | — | |
| 12 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 2.67% | — | — | |
| 13 | CLDX | Celldex Therapeutics INC | Stock-Other | 2.06% | — | — | |
| 14 | SURFUSD | Surface Oncology INC | Stock-Other | 1.96% | — | -62.79% | |
| 15 | ACRS | Aclaris Therapeutics INC | Stock-Other | 1.86% | — | — | |
| 16 | COGT | Cogent Biosciences INC | Stock-Other | 1.80% | -0.64% | — | |
| 17 | ✓ | Aligos Therapeutics INC | Stock-Other | 1.65% | — | — | |
| 18 | GRTX | Galera Therapeutics INC | Stock-Other | 1.38% | — | +1676.97% | |
| 19 | SPRY | Ars Pharmaceuticals INC | Stock-Other | 1.02% | — | — | |
| 20 | ✓ | Bctg Acquisition CORP | Stock-Other | 0.84% | — | — | |
| 21 | ✓ | Metacrine INC | Stock-Other | 0.80% | — | -39.35% | |
| 22 | FPRX | Five Prime Therapeutics INC | Stock-Other | 0.61% | — | — | |
| 23 | BCABGBP | Bioatla INC | Stock-Other | 0.50% | — | — | |
| 24 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.42% | — | — | |
| 25 | VRDN | Viridian Therapeutics INC | Stock-Other | 0.05% | -3.14% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Athira Pharma INC | +3% | +11.17% | Add |
| 2 | KROS | Keros Therapeutics INC | +1.9% | — | Unchanged |
| 3 | SNDX | Syndax Pharmaceuticals INC | +1.8% | +78.24% | Add |
| 4 | GRTX | Galera Therapeutics INC | +1.3% | +1676.97% | Add |
| 5 | CNST | Constellation Pharmaceutical | +1.1% | — | Unchanged |
| 6 | TSHA | Taysha Gene Therapies INC | -0.1% | — | Unchanged |
| 7 | ✓ | Bctg Acquisition CORP | -0.2% | — | Unchanged |
| 8 | CLDX | Celldex Therapeutics INC | -0.3% | — | Unchanged |
| 9 | KURA | Kura Oncology INC | -0.7% | — | Unchanged |
| 10 | ✓ | Metacrine INC | -1.5% | -39.35% | Trim |
| 11 | RLMD | Relmada Therapeutics INC | -1.8% | — | Unchanged |
| 12 | SURFUSD | Surface Oncology INC | -3.3% | -62.79% | Trim |
| 13 | ALT | Altimmune INC | -4.2% | — | Unchanged |
| 14 | TREUR | Trillium Therapeutics INC | -11.3% | -43.92% | Trim |
| 15 | OLMA | Olema Pharmaceuticals INC | — | NEW | New buy |
| 16 | KNTEUSD | Kinnate Biopharma INC | — | NEW | New buy |
| 17 | MRNS* | Marinus Pharmaceuticals INC | — | NEW | New buy |
| 18 | HGENEUR | Humanigen INC | — | EXIT | Sold out |
| 19 | VTGNUSD | Vistagen Therapeutics INC | — | NEW | New buy |
| 20 | CRDF | Cardiff Oncology INC | — | EXIT | Sold out |
| 21 | IMV1EUR | Imv INC | — | EXIT | Sold out |
| 22 | MRNSUSD | Marinus Pharmaceuticals INC | — | EXIT | Sold out |
| 23 | ACRS | Aclaris Therapeutics INC | — | NEW | New buy |
| 24 | COGT | Cogent Biosciences INC | — | NEW | New buy |
| 25 | ALXO | Alx Oncology Holdings INC | — | EXIT | Sold out |
| 26 | ✓ | Aligos Therapeutics INC | — | NEW | New buy |
| 27 | ✓ | Unum Therapeutics INC | — | EXIT | Sold out |
| 28 | SPRY | Ars Pharmaceuticals INC | — | NEW | New buy |
| 29 | ✓ | Fs Dev CORP | — | EXIT | Sold out |
| 30 | FPRX | Five Prime Therapeutics INC | — | NEW | New buy |
| 31 | BCABGBP | Bioatla INC | — | NEW | New buy |
| 32 | MDNAF | Medicenna Therapeutics CORP | — | EXIT | Sold out |
| 33 | VRDN | Viridian Therapeutics INC | — | NEW | New buy |